이상반응 보고
| VAERS ID | 2292111 |
|---|---|
| 성별 | 여성 |
| 나이 | 25세 |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2022-03-25 |
| 발병일 | 2022-03-25 |
| 상태 | 입원 회복 |
증상
- 임신 중 노출(Exposure during pregnancy)
- 제왕 절개(Caesarean section)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Caesarean section/G1P1 VIA CS; received BNT162b2 (COMIRNATY), on 25Mar2022 as dose 1; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from Regulatory Authority.
Regulatory number: PH-PHFDA-300145969 (RA).
A 25-year-old female patient (pregnant) received BNT162b2 (COMIRNATY), on 25Mar2022 as dose 1, single (Batch/Lot number: unknown) at the age of 25 years and on 19Apr2022 as dose 2, single (Batch/Lot number: unknown), all intramuscular for covid-19 immunisation.
The patient's relevant medical history and concomitant medications were not reported.
The following information was reported: CAESAREAN SECTION (hospitalization) with onset 30Apr2022, described as "Caesarean section/G1P1 VIA CS" with Outcome Recovered/Resolved; MATERNAL EXPOSURE DURING PREGNANCY (non-serious) with onset 25Mar2022, described as "received BNT162b2 (COMIRNATY), on 25Mar2022 as dose 1", with Outcome Unknown.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.